Direxion Fallen Knives ETF logo

Direxion Fallen Knives ETF (NIFE)

Market Closed
12 Jun, 20:00
ARCA ARCA
$
45. 20
-1.18
-2.5461%
$
2.26M Market Cap
- P/E Ratio
0.83% Div Yield
720 Volume
- Eps
$ 46.38
Previous Close
Add Transaction
Day Range
44.77 45.2
Year Range
44.77 45.2
Want to track NIFE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

NIFE closed Thursday lower at $45.2, a decrease of -2.5461% from Wednesday's close, completing a monthly increase of 0% or $45.2. Over the past 12 months, NIFE stock gained 0%.
NIFE pays dividends to its shareholders, with the most recent payment made on Sep 30, 2022. The next estimated payment will be in 30 Sep 2022 on Sep 30, 2022 for a total of $45.36364.
The stock of the company had never split.
The company's stock is traded on one exchange.

NIFE Chart

Direxion Fallen Knives ETF (NIFE) FAQ

What is the stock price today?

The current price is $45.20.

On which exchange is it traded?

Direxion Fallen Knives ETF is listed on ARCA.

What is its stock symbol?

The ticker symbol is NIFE.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.83%.

What is its market cap?

As of today, the market cap is 2.26M.

Has Direxion Fallen Knives ETF ever had a stock split?

No, there has never been a stock split.

Direxion Fallen Knives ETF Profile

Financial Services Industry
Financials Sector
- CEO
ARCA Exchange
25460G757 CUSIP
US Country
- Employees
30 Sep 2022 Last Dividend
- Last Split
- IPO Date

Overview

Our fund primarily focuses on investing in a unique subset of the U.S. equity market. Specifically, we aim to allocate at least 80% of our assets toward securities that are part of an index or have similar economic characteristics to those securities. This approach is not usual in the investment world; however, it is our belief that it allows us to target companies that have gone through significant share price reductions over the past year yet exhibit strong financial health. This financial resilience suggests that these companies hold the potential for share price recovery in the future. It's important to note that our investment strategy renders our fund non-diversified, focusing on a specific segment of the market, as designed by Indxx, LLC. This targeted approach is central to our investment philosophy and objectives.

Products and Services

Our primary offering centers around a targeted investment fund with a distinct focus on recovery potential within the U.S. equity market. Listed below are the key aspects of our products and services:

  • Securities Investment
  • We invest a significant portion of our assets in securities that are either part of a specific index or possess similar economic characteristics to those within the index. This index, designed by Indxx, LLC, includes U.S. equity securities that have shown substantial share price declines over the last year but are assessed to have solid financial health, hinting at the possibility of future recovery.

  • Focus on Financial Health and Recovery Potential
  • In choosing our investments, we specifically look for companies that, despite their recent price drops, exhibit strong underlying financial health. Our strategy is grounded in the belief that such companies are likely to rebound, offering our investors a chance for significant gains. This approach requires a meticulous evaluation of each company's financial condition and prospects for price recovery.

  • Non-Diversified Fund Strategy
  • Our fund adopts a non-diversified investment strategy, meaning we invest in a concentrated selection of securities. This approach allows us to target our investments more precisely but also involves a higher level of risk compared to diversified funds. Our focus is squarely on a subset of the market—those companies identified by Indxx, LLC's index as having potential for recovery based on their financial health and recent share price declines.

Contact Information

Address: 1301 Avenue of the Americas, 28th Floor
Phone: 866-476-7523